Treatment toxicities and their impact on oral intake following non-surgical management for head and neck cancer: a 3-year longitudinal study

Purpose Patients who receive (chemo)radiotherapy [(C)RT] for head and neck cancer (HNC) experience multiple treatment effects. However, the presence and recovery of treatment toxicities and how these impact on oral intake over time post-treatment are not fully understood. The primary aim of this stu...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2018-07, Vol.26 (7), p.2341-2351
Main Authors: Barnhart, Molly K., Robinson, Rachelle A., Simms, Virginia A., Ward, Elizabeth C., Cartmill, Bena, Chandler, Sophie J., Smee, Robert I.
Format: Article
Language:English
Subjects:
Aged
Cancer research
Care and treatment
Chemoradiotherapy - adverse effects
Chemotherapy
Cohort Studies
Deglutition disorders
Drug therapy
Female
Head & neck cancer
Head and neck cancer
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - therapy
Humans
Longitudinal Studies
Male
Medicine
Medicine & Public Health
Middle Aged
Nursing
Nursing Research
Oncology
Original Article
Pain Medicine
Radiotherapy
Rehabilitation Medicine
Surgery
Time Factors
Toxicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Patients who receive (chemo)radiotherapy [(C)RT] for head and neck cancer (HNC) experience multiple treatment effects. However, the presence and recovery of treatment toxicities and how these impact on oral intake over time post-treatment are not fully understood. The primary aim of this study was to examine patient perceptions of the toxicities present and which are barriers to oral intake, up to 3 years post (C)RT. The secondary aim was to identify mealtime strategies used to optimise oral intake. Methods A prospective cohort of 96 patients after completion of (C)RT for HNC reported the presence of toxicities, if they were barriers to oral intake, and use of any mealtime strategies at the end of treatment (EoT), and at 3, 6, 12, 24, and 36 months post-treatment. Results All toxicities and reported barriers changed over time ( p  
ISSN:0941-4355
1433-7339
DOI:10.1007/s00520-018-4076-6